Carol Peña
- Molecular Biology top 10%
- Endocrinology, Diabetes and Metabolism top 1%
- Pulmonary and Respiratory Medicine top 2%
- Oncology top 5%
- Cancer Research top 5%
- Co-authors
- Furio PaciniRalf PaschkeSteven I. ShermanChristelle de la FouchardièreChristopher M. NuttingLars BastholtBarbara JarząbIstván Molnár
- Topics
- Hepatocellular Carcinoma Treatment and Prognosis (2 papers)Cancer Genomics and Diagnostics (2 papers)Colorectal Cancer Treatments and Studies (2 papers)
- Partner nations
- FranceUnited StatesGermany
In The Last Decade
Carol Peña
9 papers receiving 2.3k citations
Hit Papers
Peers
Comparison fields: 5 of 70
- Molecular Biology 910
- Endocrinology, Diabetes and Metabolism 910
- Pulmonary and Respiratory Medicine 875
- Oncology 765
- Cancer Research 492
Countries citing papers authored by Carol Peña
This map shows the geographic impact of Carol Peña's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carol Peña with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carol Peña more than expected).
Fields of papers citing papers by Carol Peña
This network shows the impact of papers produced by Carol Peña. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carol Peña. The network helps show where Carol Peña may publish in the future.
Co-authorship network of co-authors of Carol Peña
This figure shows the co-authorship network connecting the top 25 collaborators of Carol Peña. A scholar is included among the top collaborators of Carol Peña based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carol Peña. Carol Peña is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 192 | |
| 3 | 14 | |
| 4 | 93 | |
| 5 | Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trialbreakdown → | 1153 |
| 6 | 5 | |
| 7 | Sorafenib for Treatment of Renal Cell Carcinoma: Final Efficacy and Safety Results of the Phase III Treatment Approaches in Renal Cancer Global Evaluation Trialbreakdown → | 864 |
| 8 | 9 | |
| 9 | 10 |
About Carol Peña
Carol Peña is a scholar working on Hepatology, Cancer Research and Endocrinology, Diabetes and Metabolism, having authored 9 papers that have together received 2.3k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (2 papers), Cancer Genomics and Diagnostics (2 papers) and Colorectal Cancer Treatments and Studies (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (910 citations), Cancer Research (492 citations) and Oncology (765 citations). Carol Peña has collaborated with scholars based in France, United States and Germany. Frequent co-authors include Furio Pacini, Ralf Paschke, Steven I. Sherman, Christelle de la Fouchardière, Christopher M. Nutting, Lars Bastholt, Barbara Jarząb, István Molnár, Martin Schlumberger and John Chung. Their work appears in journals such as The Lancet, Journal of Clinical Oncology and Journal of Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.